Correspondence: Dr Feldman, Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071 (sfeldman@wfubmc.edu).
Accepted for Publication: May 19, 2011.
Author Contributions: Drs Yentzer and Feldman had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Yentzer, Sagransky, and Feldman. Acquisition of data: Yentzer, O ’Neill, Clark, and Williams. Analysis and interpretation of data: Yentzer, Wood, O ’Neill, Clark, and Feldman. Drafting of the manuscript: Yentzer, Wood, Sagransky, and O ’Neill. Critical revision of the manuscript for important intellectual content: Yentzer, Clark, Williams, and Feldman. Statistical analysis: Yentzer. Obtained funding: Yentzer. Administrative, technical, and material support: Clark and Williams. Study supervision: Yentzer and Feldman.
Financial Disclosure: Dr Feldman has received grant support and has been a speaker and consultant for Galderma Laboratories LP, Connetics Corp, Abbott Laboratories, Warner Chilcott, Centocor, Amgen, Biogenidec, and Bristol-Myers Squibb Dermatology. He has received grant support from Astellas, Coria, Pharmaderm, the National Psoriasis Foundation, Ortho Pharmaceuticals, Aventis Pharmaceuticals, and Roche Dermatology. He has received research support and stock options from and been a consultant for Photomedex; has received research support from and been a consultant and speaker for Genentech; has received grant support from and been a speaker for 3M; and has received research support from and been a speaker for Novartis. He has received research grants from the Dermatology Foundation and the American Society for Dermatologic Surgery. Dr Feldman receives separate departmental funding from Acuderm, Advanced Tissue Sciences, Allergan, Aventis, Bristol-Myers Squibb, Combe, Curatek, Ferndale, Fujisawa, Hermal, Hoffman LaRoche, Galderma Laboratories LP, Genderm, Glaxo Wellcome, Hill, Janssen, Mayrand, NeoStrata, Neutrogena, Novartis, Oclassen, Ortho, Person & Covey, Proctor & Gamble, RJR Nabisco, Schering-Plough, Shelton, SmithKline, Stiefel, 3M, United Catalyst, Upjohn, and Wolff Systems.
Funding/Support: This study was supported by a research grant from the American Acne and Rosacea Society. The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories LP.
Role of the Sponsors: The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; or in the preparation, review, or approval of the manuscript.